(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
0.88% $ 107.34
Live Chart Being Loaded With Signals
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery...
Stats | |
---|---|
Volumen de hoy | 852.00 |
Volumen promedio | 934.00 |
Capitalización de mercado | 9.60B |
EPS | $1.030 ( 2023-06-30 ) |
Last Dividend | $1.174 ( 2023-03-23 ) |
Next Dividend | $0 ( N/A ) |
P/E | 32.33 |
ATR14 | $0.276 (0.26%) |
Carl Zeiss Meditec AG Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Carl Zeiss Meditec AG Finanzas
Annual | 2023 |
Ingresos: | $2.09B |
Beneficio Bruto: | $1.21B (57.71 %) |
EPS: | $3.25 |
FY | 2023 |
Ingresos: | $2.09B |
Beneficio Bruto: | $1.21B (57.71 %) |
EPS: | $3.25 |
FY | 2022 |
Ingresos: | $1.90B |
Beneficio Bruto: | $1.13B (59.26 %) |
EPS: | $3.29 |
FY | 2021 |
Ingresos: | $1.65B |
Beneficio Bruto: | $967.21M (58.73 %) |
EPS: | $2.64 |
Financial Reports:
No articles found.
Carl Zeiss Meditec AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$1.174 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.527 | 2013-03-01 |
Last Dividend | $1.174 | 2023-03-23 |
Next Dividend | $0 | N/A |
Payout Date | 2023-04-11 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | $7.38 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.86 | -- |
Div. Sustainability Score | 3.69 | |
Div.Growth Potential Score | 4.66 | |
Div. Directional Score | 4.17 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RWCB | Ex Dividend Knight | 2023-07-28 | Quarterly | 0 | 0.00% | |
FIDS | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
WEGZY | Ex Dividend Knight | 2023-09-29 | Bi-Monthly | 0 | 0.00% | |
MAORF | Ex Dividend Junior | 2023-08-17 | Sporadic | 0 | 0.00% | |
CLZNY | Ex Dividend Knight | 2023-06-09 | Annually | 0 | 0.00% | |
SNMCY | Ex Dividend Junior | 2023-08-18 | Semi-Annually | 0 | 0.00% | |
HCBC | Ex Dividend Knight | 2023-08-10 | Quarterly | 0 | 0.00% | |
AMFC | Ex Dividend Knight | 2023-08-31 | Annually | 0 | 0.00% | |
NHYDY | Ex Dividend Knight | 2023-05-11 | Annually | 0 | 0.00% | |
CSXXY | Ex Dividend Knight | 2023-09-15 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.132 | 1.500 | 7.36 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.134 | 1.500 | 9.62 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 24.02 | 1.000 | 2.22 | 2.22 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.33 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.573 | 1.000 | 3.78 | 3.78 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.196 | 1.000 | 8.08 | 8.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 32.28 | 1.000 | 6.84 | 0 | [1 - 100] |
returnOnEquityTTM | 0.134 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.55 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.189 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -28.41 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.112 | 1.000 | 9.71 | 0 | [0.1 - 0.5] |
Total Score | 4.66 |
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico